Aytu Biopharma (AYTU) Times Interest Earned (2010 - 2026)
Aytu Biopharma's (AYTU) quarterly Times Interest Earned came in at -$0.2 in Q1 2026, down 140.45% year-on-year from $0.49 in Q1 2025, and down 106.3% on a QoQ basis from -$0.1 in Q4 2025.
Aytu Biopharma (AYTU) Times Interest Earned (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 17 years of Times Interest Earned data on file, last reported at -$0.2 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 140.45% year-over-year to -$0.2 in Q1 2026; TTM through Mar 2026 was -$0.73, a 47.48% decrease from a year earlier, with the FY2025 full-year figure at -$0.06, down 394.3% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.2, down from -$0.1 in the prior quarter.
- Over the last five years, Times Interest Earned for AYTU reached as high as $5.18 in Q2 2025 and fell as low as -$6.16 in Q2 2022.
- Historically, Times Interest Earned has averaged -$0.3 across 5 years, with a median of -$0.07 in 2025.
- Across the five-year window, Times Interest Earned surged 403.51% in 2023 and plunged 714790.97% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$0.21 in 2022, then jumped by 403.51% to $0.63 in 2023, then slumped by 110.9% to -$0.07 in 2024, then slumped by 38.41% to -$0.1 in 2025, then tumbled by 106.3% to -$0.2 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.2 in Q1 2026, -$0.1 in Q4 2025, and -$0.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.10 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | 5.18 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.19 |
| Jun 30, 2024 | -2.60 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | 0.63 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | -6.16 |
| Mar 31, 2022 | -1.37 |
| Dec 31, 2021 | -1.78 |
| Sep 30, 2021 | -0.69 |
| Jun 30, 2021 | -120.36 |